Literature DB >> 34339004

Effect of Telmisartan on Arsenic-Induced (Sub-chronic) Perturbations in Redox Homeostasis, Pro-inflammatory Cascade and Aortic Dysfunction in Wistar Rats.

B Rudresh Gowda1, N Prakash2, C R Santhosh1, B H Pavithra1, Rashmi Rajashekaraiah1, M L Sathyanarayana3, Suguna Rao3, Prashantkumar Waghe4, K R Anjan Kumar3, G R Shivaprasad1, Y Muralidhar1.   

Abstract

An experimental study was conducted in male Wistar rats to explore the antioxidant potential of telmisartan (an AT1 receptor blocker) to overcome arsenic ('As')-induced perturbations in redox homeostasis pro-inflammatory cytokines, prostaglandin-E2 levels and aortic dysfunction in Wistar rats. Wistar rats were randomly divided into four groups of six each. Group-I served as untreated control, while group-II received sodium (meta) arsenite (NaAsO2) (10 mg/kg b.wt. p.o) for a period of 60 days. Experimental rats in group-III received treatment similar to group-II, but in addition received telmisartan (with 1% aqueous solution of Tween 80) @ 10 mg/kg b.wt. (p.o) for a similar duration, while rats in group-IV received telmisartan alone. Arsenic exposure resulted in significant (p < 0.05) elevation in the levels of superoxide anion ([Formula: see text]) radicals (control: 768.20 ± 126.77 vs group-II: 1232.75 ± 97.85 pmol of NBT reduced/min/mg protein). Telmisartan administration showed significant (p < 0.05) reduction in [Formula: see text] generation (815.34 ± 43.41 pmol of NBT reduced/min/mg protein). Sub-chronic exposure to 'As' significantly (p < 0.05) decreased the activities of SOD, CAT, GPx and GR activity and GSH levels in the aorta, thus induced lipid peroxidation (LPO) measured as measured in terms of thiobarbituric acid reactive substances (TBARS) called as malondialdehyde (MDA). However, the administration of telmisartan effectively countered the LPO (24.03 ± 1.18 nmol of MDA/g) on account of restoring the levels of aforesaid antioxidant defense system. Telmisartan administration effectively attenuated the 'As'-induced surge in pro-inflammatory cytokines (viz., IL-1β, IL-6 and TNF-α) levels, as well as countered the activity of cyclooxygenase (COX2) as indicated by a significant (p < 0.05) decrease in PGE2 level in the aorta. In addition to it, there was a significant (p < 0.05) decrease in plasma angiotensin II (Ang-II) levels in experimental rats receiving telmisartan. Quantitative RT-PCR studies revealed that sub-chronic exposure to 'As' upregulated the Nox2 mRNA expression, but there was a 1.2-fold reduction in expression level upon co-administration of telmisartan. Histopathological examination revealed marked recovery from 'As'-induced disruption of tunica adventitia and loss of connective tissue in experimental rats receiving telmisartan. The study concludes that telmisartan can overcome aortic dysfunction induced by sub-chronic exposure to arsenic through drinking water in experimental rats through restoration of redox balance, attenuation of pro-inflammatory cytokines and mediators and downregulation of Nox2 mRNA expression.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Aorta; Arsenic; Redox homeostasis; Sub-chronic; Telmisartan; Wistar rats

Mesh:

Substances:

Year:  2021        PMID: 34339004     DOI: 10.1007/s12011-021-02804-0

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  46 in total

1.  Arsenic-induced cell death in liver and brain of experimental rats.

Authors:  Somia Bashir; Yukti Sharma; M Irshad; S Dutta Gupta; T D Dogra
Journal:  Basic Clin Pharmacol Toxicol       Date:  2006-01       Impact factor: 4.080

2.  Arsenic exposure induces genomic hypermethylation.

Authors:  Sunipa Majumdar; Sarmishtha Chanda; Bhaswati Ganguli; D N Guha Mazumder; Sarbari Lahiri; Uma B Dasgupta
Journal:  Environ Toxicol       Date:  2010-06       Impact factor: 4.119

3.  Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite.

Authors:  A Barchowsky; L R Klei; E J Dudek; H M Swartz; P E James
Journal:  Free Radic Biol Med       Date:  1999-12       Impact factor: 7.376

Review 4.  Arsenic: toxicity, oxidative stress and human disease.

Authors:  K Jomova; Z Jenisova; M Feszterova; S Baros; J Liska; D Hudecova; C J Rhodes; M Valko
Journal:  J Appl Toxicol       Date:  2011-02-14       Impact factor: 3.446

Review 5.  Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage.

Authors:  N Ercal; H Gurer-Orhan; N Aykin-Burns
Journal:  Curr Top Med Chem       Date:  2001-12       Impact factor: 3.295

Review 6.  Oxidative mechanism of arsenic toxicity and carcinogenesis.

Authors:  Honglian Shi; Xianglin Shi; Ke Jian Liu
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

7.  Arsenic speciation in tissues of the Mediterranean polychaete Sabella spallanzanii.

Authors:  Daniele Fattorini; Francesco Regoli
Journal:  Environ Toxicol Chem       Date:  2004-08       Impact factor: 3.742

Review 8.  Arsenic and atherosclerosis.

Authors:  Petia P Simeonova; Michael I Luster
Journal:  Toxicol Appl Pharmacol       Date:  2004-08-01       Impact factor: 4.219

Review 9.  Arsenic in groundwater: a threat to sustainable agriculture in South and South-east Asia.

Authors:  Hugh Brammer; Peter Ravenscroft
Journal:  Environ Int       Date:  2008-12-24       Impact factor: 9.621

10.  Enhanced ROS production and redox signaling with combined arsenite and UVA exposure: contribution of NADPH oxidase.

Authors:  Karen L Cooper; Ke Jian Liu; Laurie G Hudson
Journal:  Free Radic Biol Med       Date:  2009-05-03       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.